Klotho Neurosciences, Stock Market Value
| KLTO Stock | 0.36 0.03 7.69% |
| Symbol | Klotho |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences,. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Klotho Neurosciences, is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences,'s value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences,'s market value can be influenced by many factors that don't directly affect Klotho Neurosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Klotho Neurosciences, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Klotho Neurosciences,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Klotho Neurosciences,.
| 01/04/2024 |
| 12/24/2025 |
If you would invest 0.00 in Klotho Neurosciences, on January 4, 2024 and sell it all today you would earn a total of 0.00 from holding Klotho Neurosciences, or generate 0.0% return on investment in Klotho Neurosciences, over 720 days. Klotho Neurosciences, is related to or competes with Cadrenal Therapeutics,, Rallybio Corp, Exicure, Minerva Neurosciences, IBio, Common, Neurosense Therapeutics, and TAO Synergies. More
Klotho Neurosciences, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Klotho Neurosciences,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Klotho Neurosciences, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.16) | |||
| Potential Upside | 11.63 |
Klotho Neurosciences, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Klotho Neurosciences,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Klotho Neurosciences,'s standard deviation. In reality, there are many statistical measures that can use Klotho Neurosciences, historical prices to predict the future Klotho Neurosciences,'s volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | 0.5662 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Klotho Neurosciences,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Klotho Neurosciences, Backtested Returns
Klotho Neurosciences, has Sharpe Ratio of -0.0415, which conveys that the firm had a -0.0415 % return per unit of risk over the last 3 months. Klotho Neurosciences, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Klotho Neurosciences,'s Standard Deviation of 6.26, mean deviation of 4.8, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.48, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Klotho Neurosciences, are expected to decrease at a much lower rate. During the bear market, Klotho Neurosciences, is likely to outperform the market. At this point, Klotho Neurosciences, has a negative expected return of -0.26%. Please make sure to verify Klotho Neurosciences,'s total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Klotho Neurosciences, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.4 |
Poor reverse predictability
Klotho Neurosciences, has poor reverse predictability. Overlapping area represents the amount of predictability between Klotho Neurosciences, time series from 4th of January 2024 to 29th of December 2024 and 29th of December 2024 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Klotho Neurosciences, price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Klotho Neurosciences, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.15 |
Klotho Neurosciences, lagged returns against current returns
Autocorrelation, which is Klotho Neurosciences, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Klotho Neurosciences,'s stock expected returns. We can calculate the autocorrelation of Klotho Neurosciences, returns to help us make a trade decision. For example, suppose you find that Klotho Neurosciences, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Klotho Neurosciences, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Klotho Neurosciences, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Klotho Neurosciences, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Klotho Neurosciences, stock over time.
Current vs Lagged Prices |
| Timeline |
Klotho Neurosciences, Lagged Returns
When evaluating Klotho Neurosciences,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Klotho Neurosciences, stock have on its future price. Klotho Neurosciences, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Klotho Neurosciences, autocorrelation shows the relationship between Klotho Neurosciences, stock current value and its past values and can show if there is a momentum factor associated with investing in Klotho Neurosciences,.
Regressed Prices |
| Timeline |
Pair Trading with Klotho Neurosciences,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences, will appreciate offsetting losses from the drop in the long position's value.Moving together with Klotho Stock
Moving against Klotho Stock
| 0.68 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.68 | DSGN | Design Therapeutics | PairCorr |
| 0.62 | 0P6S | Bayer AG NA | PairCorr |
| 0.58 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.58 | VCYT | Veracyte | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences, to buy it.
The correlation of Klotho Neurosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Klotho Neurosciences, Correlation, Klotho Neurosciences, Volatility and Klotho Neurosciences, Alpha and Beta module to complement your research on Klotho Neurosciences,. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences, guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Klotho Neurosciences, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.